Opportunity Information: Apply for PAR 23 156
The Lasker Clinical Research Scholars Program (PAR 23-156) is a National Institutes of Health (NIH) grant opportunity designed to help launch and sustain the early independent careers of clinical researchers. Its main goal is to give promising clinician-scientists the protected time, resources, and institutional setting needed to build a truly independent research program, with a strong emphasis on research that can meaningfully affect human health. A defining feature of the program is that it intentionally connects the NIH intramural research environment with the broader extramural academic and research community, creating a structured pathway that starts inside NIH and can later transition outward while maintaining NIH support. The notice indicates the award is "Clinical Trial Optional," meaning applicants may propose studies that include clinical trials if appropriate, but proposing a trial is not required.
The program is structured in two phases. Phase 1 places selected Lasker Scholars as tenure-track investigators within the NIH Intramural Research Program (IRP) for up to 5 to 7 years. During this period, scholars are expected to operate as independent investigators and are provided independent research budgets, allowing them to establish a lab or research team, generate foundational data, publish, and develop a coherent clinical research agenda. Phase 2 is designed as a bridge to longer-term independence and broader positioning in the biomedical research ecosystem. Successful scholars may receive up to 3 additional years of NIH support to continue their research at an extramural research facility (for example, a university or other eligible research organization). Alternatively, rather than moving to an external institution, a scholar may be considered to remain as an investigator within the NIH intramural program, reflecting that the program is meant to be flexible about where a scholar ultimately builds their long-term career, as long as the research trajectory remains strong and impactful.
From an applicant eligibility standpoint, the opportunity is broad in terms of organizational types that can apply, which is typical of NIH funding announcements. Eligible applicants include various levels of U.S. government entities (state, county, city/township, and special district governments), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, and a wide range of nonprofit organizations (both 501(c)(3) and non-501(c)(3), as long as they are not institutions of higher education in those specific categories). For-profit organizations other than small businesses, as well as small businesses, are also listed among eligible applicants, along with Native American tribal governments (federally recognized) and tribal organizations that are not federally recognized. The announcement also explicitly highlights categories of "other eligible applicants" that NIH often seeks to encourage, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions. These inclusions reinforce that the program is open to a diverse set of institutional environments and is compatible with a wide range of research settings.
At the same time, the funding opportunity is clear about restrictions involving foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined under the NIH Grants Policy Statement) are not allowed. In practical terms, this means the applicant organization and the supported activities must be U.S.-based without foreign components as part of the proposed project structure under this specific announcement.
Administratively, the opportunity is offered as a discretionary grant under NIH, with activity categories spanning education, environment, food and nutrition, and health, reflecting the broad cross-cutting nature of clinical and translational research supported across NIH institutes and centers. Multiple CFDA numbers are associated with the program (including 93.113, 93.172, 93.173, 93.213, 93.233, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.866, and 93.879), which generally signals participation or alignment with multiple NIH components. The opportunity lists an original closing date of August 25, 2023, and a creation date of April 17, 2023. The source information provided does not specify an award ceiling or the expected number of awards, so those specifics would typically need to be confirmed in the full FOA text or related NIH documentation.
Overall, this program is best understood as a career-shaping, two-step mechanism: first, a substantial intramural tenure-track appointment with resources to develop independence, followed by a time-limited extramural support option (or potential continuation intramurally) that helps scholars transition into stable, long-term independent clinical research roles. The intent is not just to fund a project, but to invest in the researcher and give them a platform that combines NIH intramural strengths with an eventual pathway into the broader external research community.Apply for PAR 23 156
- The National Institutes of Health in the education, environment, food and nutrition, health sector is offering a public funding opportunity titled "Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.172, 93.173, 93.213, 93.233, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.866, 93.879.
- This funding opportunity was created on 2023-04-17.
- Applicants must submit their applications by 2023-08-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): Lasker Clinical Research Scholars Program (PAR 23-156)
What is the Lasker Clinical Research Scholars Program (PAR 23-156)?
The Lasker Clinical Research Scholars Program is a National Institutes of Health (NIH) grant opportunity intended to launch and sustain the early independent careers of clinical researchers. It is designed to provide protected time, resources, and an institutional environment that supports building a genuinely independent research program, with a strong emphasis on research that can meaningfully affect human health.
What is the main purpose of this program?
The program aims to invest in promising clinician-scientists by giving them the support needed to establish independence as clinical researchers. The emphasis is on building a durable, impactful research trajectory, not just completing a single short-term project.
What makes this program different from a typical NIH grant?
A defining feature is the structured connection between the NIH intramural research environment and the broader extramural academic and research community. The pathway begins within NIH (intramural) and can later transition outward (extramural) while maintaining NIH support, creating a bridge between the two ecosystems.
Is this funding opportunity limited to clinical trials?
No. The notice states "Clinical Trial Optional." Applicants may propose research that includes a clinical trial if appropriate, but proposing a clinical trial is not required.
How is the program structured?
The program has two phases. Phase 1 places selected scholars in the NIH Intramural Research Program (IRP) as tenure-track investigators for up to 5 to 7 years. Phase 2 can provide up to 3 additional years of NIH support to continue research at an extramural research facility (such as a university or other eligible research organization), or a scholar may be considered to remain within NIH intramurally.
What happens in Phase 1 (NIH intramural phase)?
In Phase 1, Lasker Scholars serve as tenure-track investigators within the NIH Intramural Research Program for up to 5 to 7 years. Scholars are expected to function as independent investigators and are provided independent research budgets to establish a lab or research team, generate foundational data, publish, and develop a coherent clinical research agenda.
How long can Phase 1 last?
Phase 1 can last up to 5 to 7 years within the NIH Intramural Research Program (IRP).
What happens in Phase 2 (transition/bridge phase)?
Phase 2 is intended to support longer-term independence and broader positioning in the biomedical research ecosystem. Successful scholars may receive up to 3 additional years of NIH support to continue their research at an extramural research facility. Alternatively, rather than moving externally, a scholar may be considered to remain as an investigator within the NIH intramural program.
How long can Phase 2 support last?
Phase 2 can provide up to 3 additional years of NIH support.
Is moving to an extramural institution required in Phase 2?
No. The program is described as flexible. A successful scholar may transition to an extramural research facility with NIH support, or may be considered to remain within the NIH intramural program, depending on the scholar's trajectory and program decisions.
What kinds of organizations are eligible to apply?
The eligible applicant types listed are broad and include: state governments, county governments, city or township governments, special district governments, independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3), in the categories specified), for-profit organizations other than small businesses, small businesses, federally recognized Native American tribal governments, and tribal organizations that are not federally recognized.
Does the opportunity encourage applications from specific institution types?
Yes. The announcement highlights "other eligible applicants" often encouraged by NIH, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.
Are foreign organizations eligible to apply?
No. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply under this opportunity.
Can a U.S. organization include a foreign component in the proposed project?
No. The opportunity states that non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined under the NIH Grants Policy Statement) are not allowed. In practical terms, the applicant organization and supported activities must be U.S.-based without foreign components as part of the proposed project structure for this announcement.
What is the NIH Intramural Research Program (IRP) role in this award?
Phase 1 is conducted within the NIH Intramural Research Program, where selected scholars are placed as tenure-track investigators and are expected to operate as independent investigators with independent research budgets.
What is meant by "protected time" in the program description?
Based on the description provided, "protected time" refers to providing scholars the time and support needed to focus on building an independent clinical research program, supported by resources and an institutional setting designed to enable independence and productivity.
What type of award is this?
The opportunity is offered as a discretionary grant under NIH.
What broad activity categories are associated with this opportunity?
The activity categories listed span education, environment, food and nutrition, and health, reflecting the cross-cutting nature of clinical and translational research supported across NIH institutes and centers.
What CFDA numbers are associated with this program?
The program lists multiple CFDA numbers: 93.113, 93.172, 93.173, 93.213, 93.233, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.866, and 93.879.
What are the key dates mentioned for this opportunity?
The source information provided lists a creation date of April 17, 2023, and an original closing date of August 25, 2023.
Does the provided information include an award ceiling or the expected number of awards?
No. The source information provided does not specify an award ceiling or the expected number of awards. Those details would typically need to be confirmed in the full funding opportunity announcement (FOA) text or related NIH documentation.
Is this program primarily funding a specific project or the researcher?
The description emphasizes that the intent is not just to fund a project, but to invest in the researcher by providing a platform that combines NIH intramural strengths with an eventual pathway into the broader external research community.
Browse more opportunities from the same category: Education, Environment, Food and Nutrition, Health
Next opportunity: F24AS00008 - NAWCA 2024-2 US Standard Grants
Previous opportunity: Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 156
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 156) also looked into and applied for these:
| Funding Opportunity |
|---|
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) Apply for PAR 23 219 Funding Number: PAR 23 219 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Apply for PA 23 232 Funding Number: PA 23 232 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Apply for PAR 23 298 Funding Number: PAR 23 298 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $500,000 |
| Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) Apply for PAR 24 145 Funding Number: PAR 24 145 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $125,000 |
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) Apply for PAR 24 144 Funding Number: PAR 24 144 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $100,000 |
| Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed) Apply for RFA AT 24 010 Funding Number: RFA AT 24 010 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 156", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
